ClinicalTrials.Veeva

Menu

Postoperative Electrical Muscle Stimulation (POEMS)

U

University of Nottingham

Status

Unknown

Conditions

Postoperative Complications
Muscle Atrophy

Treatments

Device: Electrical Muscle stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04199936
274048 (Other Identifier)
19089

Details and patient eligibility

About

Patients lose a significant amount of muscle following major abdominal surgery. This is partly due to a catabolic response to the surgical insult and inflammation, but is also probably due to a lack of muscle use secondary to immobility.

This study will aim to assess whether some or even all of postoperative muscle loss in the upper leg muscle group is preventable through electrical muscle stimulation to mimic physical activity.

Full description

Following major gastrointestinal surgery patients may loose around 6 % of their skeletal muscle mass in the first 5 days. Whilst some of this loss is as a result of inflammation and starvation, some is due to muscle disuse.

Studies have shown that patients spend 96% of their time being sedentary in the first 5 days following major abdominal surgery and by day 5 are still taking a median of less than 500 steps per day. Studies of healthy volunteers who undergo similar muscle disuse loose approximately 3.5% of skeletal muscle mass over the same time period, indicating that around half of postoperative muscle loss may be due to immobility.

Through the use of electrical muscle stimulation, this study will aim to mimic high levels of exercise in the quadriceps of patients who have undergo major gastrointestinal surgery to see whether this reduces or prevents muscle loss. Patients muscles will be measured using ultrasound and DXA and neuromuscular function will be measured using electromyography.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients undergoing major segmental colonic resections or gastric/oesophageal resection
  • Sufficient mobility and fitness to complete normal enhanced recovery protocols following surgery
  • Ability to give informed consent

Exclusion criteria

  • Pre-existing neuromuscular disease (including parkinson's disease)
  • Pacemaker, implantable cardiac defibrillator or other implanted nerve stimulator device
  • Metalwork in both upper legs
  • Dementia
  • Inability to give informed consent
  • Disability preventing normal mobilisation after surgery
  • Symptomatic peripheral vascular disease
  • Chronic kidney failure of chronic heart failure
  • Intubation for > 24 hours post operation
  • Return to theatre for surgical complication within first 5 days post operation

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

20 participants in 2 patient groups

EMG leg
Experimental group
Description:
Quadriceps muscle group of postoperative patients randomly selected leg which will undergo electrical muscle stimulation for upto 2 hours on each postoperative day
Treatment:
Device: Electrical Muscle stimulation
Control leg
No Intervention group
Description:
Quadriceps muscle group of postoperative patients leg not selected to undergo electrical muscle stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Bethan E Phillips, PhD; Edward J Hardy, MBBCh

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems